Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Mukdahan International Hospital PCL Debt-to-EBITDA?
Mukdahan International Hospital PCLBKK:HANN -1.18%17 Debt-to-EBITDA is 1.34 as of Mar. 2026, which is 15% above its 10-year median of 1.17. GuruFocus rates BKK:HANN with a GF Score™ of 17/100. The stock has 2 warning signs investors should review. Among 481 Healthcare Providers & Services companies, Mukdahan International Hospital PCL ranks better than 62.37% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
BKK:HANN'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.08 Med: 1.17 Max: 1.4
Current: 1.4
During the past 3 years, the highest Debt-to-EBITDA Ratio of Mukdahan International Hospital PCL was 1.40. The lowest was 1.08. And the median was 1.17.
BKK:HANN's Debt-to-EBITDA is ranked better than 62.37% of 481
companies
in the Healthcare Providers & Services industry
Industry Median: 2.19
vs BKK:HANN: 1.40
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Mukdahan International Hospital PCL Debt-to-EBITDA Related Terms
Mukdahan International Hospital PCL Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mukdahan International Hospital PCL Debt-to-EBITDA Chart
Mukdahan International Hospital PCL Annual Data
Trend
Dec23
Dec24
Dec25
Debt-to-EBITDA
1.17
1.19
1.08
Mukdahan International Hospital PCL Quarterly Data
BKK:HANN vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Mukdahan International Hospital PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mukdahan International Hospital PCL Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mukdahan International Hospital PCL's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Mukdahan International Hospital PCL's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Mukdahan International Hospital PCL (BKK:HANN) has a Debt-to-EBITDA of 1.34 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Mukdahan International Hospital PCL. This is 15% above median its historical median of 1.17. Over the past decade, Mukdahan International Hospital PCL's Debt-to-EBITDA has ranged from 1.08 to 1.40. According to the industry distribution chart, Mukdahan International Hospital PCL ranks #181 out of 481 companies in the Healthcare Providers & Services industry, placing it in the top 37.6%.
Is Mukdahan International Hospital PCL's Debt-to-EBITDA too high?
Mukdahan International Hospital PCL's current Debt-to-EBITDA of 1.34 is 15% above median its 10-year median of 1.17. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 1.40. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Mukdahan International Hospital PCL's value of 1.34 is 38.8% below this industry median. Based on the distribution chart, Mukdahan International Hospital PCL ranks #181 out of 481 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mukdahan International Hospital PCL has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Mukdahan International Hospital PCL's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mukdahan International Hospital PCL ranks #181 out of 481 companies for Debt-to-EBITDA. This puts Mukdahan International Hospital PCL in the upper half of its industry. The industry median Debt-to-EBITDA is 2.19. Mukdahan International Hospital PCL's value of 1.34 is 38.8% below this benchmark. Historically, Mukdahan International Hospital PCL's own Debt-to-EBITDA has ranged from 1.08 to 1.40 over the past decade. While the company's 10-year median is 1.17 vs. the industry median of 2.19, Mukdahan International Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 481 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mukdahan International Hospital PCL's current Debt-to-EBITDA of 1.34 is 38.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Mukdahan International Hospital PCL. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mukdahan International Hospital PCL's current Debt-to-EBITDA is 1.34, which is 15% above median its own 10-year median of 1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mukdahan International Hospital PCL stock overvalued right now?
Mukdahan International Hospital PCL (BKK:HANN) has a current Debt-to-EBITDA of 1.34. The current Debt-to-EBITDA is 1.34, which is 15% above median its 10-year median of 1.17 and 38.8% below the Healthcare Providers & Services industry median of 2.19. Mukdahan International Hospital PCL's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Mukdahan International Hospital PCL (BKK:HANN), the current Debt-to-EBITDA is 1.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mukdahan International Hospital PCL is engaged in providing comprehensive treatment services for a wide range of specialized diseases. There are three private hospitals under the company group, namely: Mukdahan International Hospital, Dr. Han Hospital, and Ruam Phaet Yasothon Hospital, which provide comprehensive services over 16 medical centers and clinics.
17GF Score
Get the complete analysis for BKK:HANN
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:HANN has been successfully added to your 
